EDN

Understand quadrature encoders with a quick technical recap

A quadrature encoder uses two output channels offset in phase to detect both direction and position with greater precision.
Investing

Applied Digital completes first phase of North Dakota AI data center

DALLAS - Applied Digital (NASDAQ:APLD) announced Monday it has successfully completed the first 50 megawatt (MW) phase of its Polaris Forge 1 AI Factory Campus in Ellendale, North Dakota, reaching ...
Business Wire

Takeda Presents Orexin Data from Landmark Oveporexton (TAK-861) Phase 3 Program in Narcolepsy Type 1 at World Sleep 2025

SINGAPORE & OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) will present data from two global Phase 3 double-blind, placebo-controlled studies of oveporexton (TAK-861) 1, ...
KTLA

SELLAS Life Sciences Announces Presentation of Phase 2 Data of SLS009 in Combination with Azacitidine and Venetoclax in Relapsed/Refractory AML with MDS-Related Changes (AML-MR ...

NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of ...
WDAF-TV

Calpine and CyrusOne Announce Phase 2 of Powered Land Agreement to Support Hyperscale Data Center at Thad Hill Energy Center in Texas

HOUSTON and DALLAS, Nov. 3, 2025 /PRNewswire/ -- Houston-based Calpine Corporation today announced the second phase of its 400-megawatt (MW) power supply agreement with Dallas-based CyrusOne, a ...
Mena FN

4DMT Announces Positive Long-Term Data From Phase 1/2 PRISM Clinical Trial In Wet AMD Supporting 4D-150'S Potential As A Backbone Therapy With Consistent And Durable Benefit ...

4D-150 demonstrated consistent and durable benefit across all three patient cohorts as evidenced by maintenance of visual acuity, control of retinal anatomy and reduction of treatment burden at all ...
Fox 5 San Diego

MLTX SHAREHOLDER ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens ...

SAN FRANCISCO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08500 (S.D.N.Y), has been filed after MoonLake (NASDAQ ...